Trial intelligence / Profile preview

Comparison of PRP, HA, Corticosteroid and Saline for Humeral Epicondylopathy

NCT04521387Phase 4Unknown

Sponsor
Wroclaw Medical University
Start
Feb 2021
Primary completion
May 2022
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of autologous platelet-rich plasma, betamethasone, hyaluronic acid in Lateral Epicondylitis (LET), sponsored by Wroclaw Medical University. Status: unknown.

02

Drugs

autologous platelet-rich plasmabetamethasonehyaluronic acid
03

Conditions

Lateral Epicondylitis (LET)

Beyond the preview

Go deeper on NCT04521387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04521387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call